Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2023

May 15, 2023

SELL
$43.42 - $57.37 $890,110 - $1.18 Million
-20,500 Closed
0 $0
Q4 2022

Feb 14, 2023

SELL
$38.8 - $55.46 $484,999 - $693,250
-12,500 Reduced 60.98%
8,000 $399,000
Q3 2022

May 15, 2023

BUY
$38.15 - $57.1 $476,875 - $713,750
12,500 Added 156.25%
20,500 $836,000
Q3 2022

Nov 14, 2022

BUY
$38.15 - $57.1 $782,075 - $1.17 Million
20,500 New
20,500 $836,000

Others Institutions Holding LEGN

About Legend Biotech Corp


  • Ticker LEGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 167,403,008
  • Market Cap $6.59B
  • Description
  • Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...
More about LEGN
Track This Portfolio

Track Sg3 Management, LLC Portfolio

Follow Sg3 Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg3 Management, LLC with notifications on news.